Earth's 'catastrophic' ice melt problem is worse than previously thought, study says
Earth's 'catastrophic' ice melt problem is worse than previously thought, study says The world's two gigantic ice sheets are in greater peril from global warming than previously thought, a study published May 20 says.
Show Caption
Hide Caption
How President Trump impacted climate change policy so far
Since taking office, President Trump has abandoned efforts to reduce global warming. It could 'take a generation or more to repair the damage."
Huge expanses of ice are melting alarmingly fast, raising new concerns about "catastrophic consequences for humanity," a study published May 20 says.
The study focuses on two masses of ice currently sitting on land: The Antarctic and Greenland ice sheets. As temperatures rise, that ice is melting, flowing into the ocean and making sea levels rise.
While change in sea level rise is often measured in centimeters or inches, the ice melt potential of these sheets could raise sea levels dozens of feet.
It's happening even faster than expected, authors warn in the study published in the journal Communications Earth and Environment.
'Recent satellite-based observations of ice sheet mass loss have been a huge wake-up call for the whole scientific and policy community working on sea-level rise and its impacts," said study co-author Jonathan Bamber, of the University of Bristol in the UK.
What is an ice sheet?
An ice sheet is a mass of glacial land ice extending more than 20,000 square miles. Ice sheets once covered much of the Northern Hemisphere during the ice age. Now, Earth has just two ice sheets: one covers most of Greenland, the largest island in the world, and the other spans across the Antarctic continent, according to the National Snow and Ice Data Center.
Together, the Antarctic and Greenland Ice Sheets contain more than 99% of the land ice and over 68% of the fresh water on Earth.
Sea levels are rising
Ice loss in Greenland and Antarctica is already influencing ocean waters and causing sea levels around the globe to rise, the NSIDC said. If global greenhouse gas emissions continue at their current rate, Earth's ice sheets are vulnerable to even more massive rapid ice loss that could substantially raise sea levels.
According to the new study, the mass of ice lost from these ice sheets has quadrupled since the 1990s and they are currently losing around 370 billion metric tons of ice per year.
Recovery could take thousands of years
Even if the Earth returns to its preindustrial temperature, it will still take hundreds to perhaps thousands of years for the ice sheets to recover. If too much ice is lost, parts of these ice sheets may not recover until the Earth enters the next ice age, the study suggests.
Study co-author Rob DeConto, from the University of Massachusetts Amherst, said, "In other words, land lost to sea level rise from melting ice sheets will be lost for a very, very long time. That's why it is so critical to limit warming in the first place.'
How hot is too hot?
The research suggests global leaders should aim for 1 degree C of warming (as compared to the Earth's temperature over a century ago) to avoid significant losses from the ice sheets and prevent a further acceleration in sea-level rise.
That's a lofty goal, considering the 1.5 degree C threshold has long been discussed as a difficult but achievable goal. (Hope has been fleeting about that goal as last year crossed that threshold).
'There is a growing body of evidence that 1.5 degrees is too high for the ice sheets in Greenland and Antarctica," study lead author Chris Stokes, from the Department of Geography at Durham University in the UK, said in a statement. "We've known for a long time that some sea-level rise is inevitable over the next few decades to centuries, but recent observations of ice sheet loss are alarming, even under current climate conditions."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
34 minutes ago
- Forbes
Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research
NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and ... More Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world. (Photo by) It was a rare moment of bipartisan unity. Standing before a joint session of Congress in January 2019, President Donald Trump boldly pledged to eradicate a disease that claims one life every single minute: HIV/AIDS. 'Scientific breakthroughs have brought a once-distant dream within reach,' Trump exclaimed. 'My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years. We have made incredible strides.' Then, he added, 'we will defeat AIDS in America and beyond.' That was then and this is now. Last week, a group of scientists working on promising HIV vaccine studies were reportedly informed that the administration plans to revoke their research grants in a move experts warn could set the movement back years. When the global AIDS crisis peaked in the early 2000s, roughly 5,000 people were dying every single day from the disease. Thanks to the leadership of governments, the private sector, and philanthropists, the world invested more resources into the AIDS fight than ever before. This spurred nearly two decades of progress—not just against AIDS, but across global health broadly. Since 2004, AIDS-related deaths have been reduced by roughly two-thirds. But recently, progress has slowed. Covid-19 proved a major health disruption that reversed years of hard-fought gains. Efforts to reduce mother-to-child transmission rates have slowed. Global health funding is now under siege not just in the United States, but across Europe, too. And the world is no longer on track to meet critical 2030 AIDS targets. The great paradox here is that never in human history has there been more tools available to fight AIDS. The cost of antiretroviral drugs has fallen from $27 a day in 2000 to as little as 10 cents a day. Now, experts say what's needed to get the fight back on track—and eventually end the threat for good—isn't just better diagnostics and therapeutics, but long acting preventatives. Fortunately, it's an area that's seen great progress. Dubbed the 'breakthrough of the year' in 2024 by the journal Science, Gilead Science's lenacapavir is a long-acting injectable vaccine that has proven incredibly effective at preventing HIV infections. It represents a major step forward from the prevalent pre-exposure prophylaxis (PrEP) pill and mitigates some of the major privacy, stigma, and adherence issues that come with taking daily medication. The next step forward could be a vaccine with even longer immunity—one that gives patients lifetime protection. Researchers have been pursuing this laudable goal for years, but last week, the Trump administration announced plans to terminate research grants at two preeminent institutions, the Duke Human Vaccine Institute and the Scripps Research Institute, totaling $258 million. The researchers were told that the administration wanted 'to go with currently available approaches to eliminate HIV.' On the other hand, global health experts are warning that without new resources, President Trump's promise to end HIV within ten years is destined to fail—and when combined with the administration's other actions to cut and halt global health programs, HIV infections and deaths could actually rise for the first time in decades under his watch. 'I find it very disappointing that, at this critical juncture, the funding for highly successful H.I.V. vaccine research programs should be pulled,' Dennis Burton, an immunologist at Scripps, told The New York Times. Meanwhile AIDS groups, including the AIDS Vaccine Advocacy Coalition described the decision as inconceivable and shortsighted. The grant news marks the latest blow to the HIV/AIDS community, which has endured devastating domestic and global funding cuts in Trump's second term. San Francisco, which was one of the first epicenters of the domestic AIDS fight, has long relied on funding from the federal government to support community-based health programs that help reduce HIV transmission. These initiatives have helped the city make outstanding progress against the disease, but Centers for Disease Control and Prevention (CDC) grant delays have threatened testing, treatment, and care continuity. Even southern states which President Trump won decisively, and which account for 50% of all new U.S. HIV infections, have not been spared. According to the Foundation for AIDS Research (amfAR), cuts to domestic HIV prevention programs could spark over 14,000 additional deaths from AIDS-related causes and 143,000 new HIV infections. Earlier this year, HHS closed its Office of Infectious Diseases & HIV policy that quarterbacked the government's domestic AIDS response. Abroad, global health programs have fared even worse. In January, the Trump administration halted funding for The President's Emergency Plan for AIDS Relief (PEPFAR), a bipartisan program that has saved over 26 million lives. In a congressional hearing last week, Secretary of State Marco Rubio said that, '85 percent of recipients are now receiving PEPFAR services.' He also said that no one has died as a result of the aid freeze, a notion journalists and health experts scoff at. According to Brooke Nichols, an infectious disease mathematical modeler and health economist at Boston University, over 57,000 adults and 6,000 children have died as a result of the PEPFAR funding freeze and the discontinuation of global health programs. Even if those numbers are inflated, as some have contended, the number of lives needlessly lost is still likely in the tens of thousands. While some experts remain hopeful that the recent cuts will eventually be restored, the prospect of an AIDS-free future that President Trump himself once espoused appears grim. "This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research," Burton warned.


The Hill
3 hours ago
- The Hill
House Oversight GOP shoots down Democratic attempt to subpoena Musk
Republicans on the House Oversight Committee shot down an attempt by the panel's Democrats to subpoena Elon Musk, seeking answers about his short stint in the Trump administration. The surprise move from Democrats to compel Musk to testify before the panel sought to examine government service that, while brief, was impactful and marred by controversy. Rep. Stephen Lynch (Mass.), the acting top Democrat on the panel, shifted the tune of a hearing on artificial intelligence (AI) by bashing the former Department of Government Efficiency (DOGE) head, saying President Trump created 'disaster and danger…by turning our government over to his biggest campaign donor.' 'We cannot sit here, however, and have the traditional bipartisan conversation about federal IT modernization without acknowledging the fact that the Trump administration, Elon Musk and DOGE are leading technology initiatives that threaten the privacy and security of all Americans and undermine our government and the vital services it provides to red states and blue states,' he said. 'Musk may say he has stepped away from his role in the federal government, but his recklessness will continue to have devastating consequences for America for years, possibly decades to come,' Lynch continued. Republicans, very few of whom were in the room when the hearing began, suspended the hearing to give GOP colleagues more time to arrive and vote down the measure, delaying the hearing for more than 20 minutes. Rep. Nancy Mace (R-S.C.), who was overseeing the hearing, mocked Democrats, telling them they 'looked good' for social media clips as her Democratic colleagues sat before blown up photos of Musk. Lynch and other Democrats pressed Mace to move forward with a vote as the wait stretched on. Rep. Jasmine Crockett (D-Texas) criticized the delay, noting that 'it has historically never taken this long for the clerk to call roll.' The Thursday push was the second time the panel's Democrats have pushed to subpoena Musk, though the first since the DOGE leader has left government following the end of his term as a special government employee. His departure also came amid reports about Musk's alleged drug use, which he has denied. Lynch said Musk was given 'free rein to terrorize our civil servants and drive more than 275,000 federal employees from their jobs serving the American people' and said he was among those in the Trump administration who are 'more interested in self enrichment than public service.' Musk officially announced his departure from the Trump administration last week, bringing to a close a tumultuous four months in government for the Tesla CEO. The tech billionaire's role leading DOGE has been highly controversial, prompting numerous lawsuits challenging Musk and his staffers' authority and creating headaches for his business empire. The move comes amid a four-way race to determine the next top Democrat to lead the panel, replacing the late Rep. Gerry Connolly. Lynch has thrown his hat in the ring, as have Crockett, Reps. Robert Garcia (D-Calif.) and Kweisi Mfume (D-Md.).
Yahoo
4 hours ago
- Yahoo
British defence giant to make satellites for Trump's missile shield
British defence giant BAE Systems is to build satellites for a new American missile-tracking system that is poised to form part of Donald Trump's 'Golden Dome'. On Thursday, the FTSE 100 company said it had secured a $1.2bn (£880m) contract from the US Space Force to provide 10 satellites for the Pentagon's missile warning and missile tracking programme. The constellation will sit in a medium Earth orbit – between 1,000 miles and 22,000 miles above the planet's surface – and track threats including intercontinental ballistic missiles and hypersonic missiles. It is eventually expected to form part of the US president's broader Golden Dome, a $175bn proposal to stitch together a network of land and space-based sensors and interceptors to shoot down missiles aimed at the United States. Lt Col Brandon Castillo, of the US Space Force, said the system being provided by BAE would 'provide accurate real-time information to decision-makers'. He added: 'This allows for additional resiliency in the missile warning and tracking satellite architecture.' The satellites will use infrared sensing technology and, along with another batch commissioned under the same programme, will have 'the ability to track hypersonic missile threats anywhere on the globe', Space Force said. They are planned for delivery from 2029 onwards. Mr Trump announced the Golden Dome plans last month, reviving an idea for a global missile shield that was first mooted by former president Ronald Reagan in the 1980s – dubbed 'Star Wars' at the time. The Reagan proposals have since been credited with kicking off a fresh arms race that piled fresh financial pressures on the Soviet Union before its eventual collapse. However, experts have questioned whether, even today, it is technically and financially feasible. The Trump administration's idea has also been partly inspired by the 'Iron Dome' missile shield used by Israel to defend itself against rocket attacks, over a smaller area. Interest in the system has grown amid fears about the capabilities of new hypersonic missiles developed by China and Russia, which American defence planners fear could slip through their defences in a conflict. Mr Trump has vowed that his system will be able to block all kinds of missiles, including nuclear weapons, using 'super technology'. 'This is very important for the success and even survival of our country. It's a pretty evil world out there,' he said last month. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.